<div id="readability-page-1"><p>In a report released today, Emmanuel Papadakis from Deutsche Bank  maintained a Hold rating on Roche Holding AG, with a price target of <span id="expert-recommendation-target">CHF265.00</span>.</p><h3>Meet Your ETF AI Analyst</h3><ul><li> Discover how TipRanks' <i>ETF</i> AI Analyst  can help you make smarter investment decisions </li><li>   Explore ETFs TipRanks' users love  and see what insights the <b><i>ETF</i> AI Analyst</b> reveals about the ones you follow.</li></ul> <p>According to TipRanks, Papadakis is a 4-star analyst with an average return of <span>3.7%</span> and a 53.29% success rate. Papadakis covers the Healthcare sector, focusing on stocks such as Novo Nordisk, AstraZeneca, and Sanofi.</p> <p>Roche Holding AG has an analyst consensus of Hold, with a price target consensus of $348.40.</p></div>

RHHBY

<p>Deutsche Bank analyst Emmanuel Papadakis has maintained a Hold rating on Roche Holding AG (RHHVF) with a price target of CHF265.00. Papadakis, a 4-star analyst with a 53.29% success rate, focuses on the Healthcare sector. The consensus for Roche Holding AG is also a Hold, with a price target consensus of $348.40.</p>

Deutsche Bank Remains a Hold on Roche Holding AG (RHHVF)